Seeking Cures For
All 16 of our Taubman Scholars are practicing physicians whose patients are an ever-present reminder of the urgent need for new cures and therapies. Their areas of expertise range from stroke and heart attack to ALS to the vision loss that is a common complication of diabetes.
A number of our scientists are seeking new treatments for a range of cancers – including a common childhood cancer – while others are working to understand conditions like obesity and skin diseases.
In just three short years, Taubman Scholars have published 94 articles in leading scientific journals, and Taubman Institute support has led to 10 human clinical trials of new treatments for disease.
To read more about how each Scholar’s approach targets specific diseases, click on the links to their research outline.
Amyotrophic lateral sclerosis (ALS)
Eva L. Feldman, M.D., Ph.D., F.A.A.N.
Cancer
Ronald J. Buckanovich, M.D., Ph.D.
Valerie P. Castle, M.D.
Arul M. Chinnaiyan, M.D., Ph.D.
Theodore s. Lawrence, M.D., Ph.D.
Erika A. Newman, M.D.
Kenneth J. Pienta, M.D.
Max S. Wicha, M.D.
Diabetes and complications of diabetes
Frank C. Brosius III, M.D.
Thomas Gardner, M.D., M.S.
Heart attack and stroke
David Ginsburg, M.D.
David J. Pinsky, M.D.
Motor neuron disease
Muscle diseases
Obesity
Charles F. Burant, M.D., Ph.D.
Skin diseases
Johann E. Gudjonsson, M.D., Ph.D.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
